Document:

EX-4.1

Exhibit 4.1

GLOBAL SECURITY

COCA-COLA BOTTLING CO. CONSOLIDATED

7.00% SENIOR NOTE DUE 2019

CUSIP No. 191098 AJ 1

THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND
IS REGISTERED IN THE NAME OF THE DEPOSITARY OR A NOMINEE OF THE DEPOSITARY, WHICH MAY BE TREATED BY
THE COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS OWNER AND HOLDER OF THIS SECURITY FOR ALL
PURPOSES.

UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST
COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER,
EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH
OTHER NAME AS IS REQUESTED BY THE AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE
& CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY
TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL
INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

 

 

COCA-COLA BOTTLING CO. CONSOLIDATED

7.00% SENIOR NOTE DUE 2019

CUSIP No. 191098 AJ 1

$110,000,000

     COCA-COLA BOTTLING CO. CONSOLIDATED, a corporation duly organized and existing under the laws
of the State of Delaware (herein called the “Company,” which term includes any successor
corporation under the Indenture hereinafter referred to), for value received, hereby promises to
pay to Cede & Co., or registered assigns, the principal sum of ONE HUNDRED TEN MILLION DOLLARS
($110,000,000) on April 15, 2019 (the “Maturity Date”), and to pay interest thereon from April 7,
2009 or from the most recent Interest Payment Date to which interest has been paid or duly provided
for, semi-annually on April 15 and October 15 of each year, commencing October 15, 2009 (each an
“Interest Payment Date”) at the rate of 7.00% per annum until the principal hereof is paid or made
available for payment, and (to the extent that the payment of such interest shall be legally
enforceable) at the rate of 7.00% per annum on any overdue principal and premium and on any overdue
installment of interest. Interest payments on this Security will be calculated on the basis of a
360-day year consisting of twelve 30-day months. If an Interest Payment Date, Redemption Date,
Change of Control Payment Date, Repayment Date or Maturity Date falls on a day that is not a
Business Day, the payment due on such date may be made on next succeeding Business Day with the
same force and effect as if made on the Interest Payment Date, Redemption Date, Change of Control
Payment Date, Repayment Date or Maturity Date, as the case may be.

     The interest so payable, and punctually paid or duly provided for, on any Interest Payment
Date will, as provided in the Indenture hereinafter referred to, be paid to the Person in whose
name this Security (or one or more Predecessor Securities) is registered at the close of business
on the Regular Record Date for such interest, which shall be the April 1 or October 1 (whether or
not a Business Day), as the case may be, next preceding such Interest Payment Date. Any such
interest not so punctually paid or duly provided for will forthwith cease to be payable to the
Holder on such Regular Record Date and may either be paid to the Person in whose name this Security
(or one or more Predecessor Securities) is registered at the close of business on a Special Record
Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be
given to each Holder of Securities of this series not less than 11 days prior to such Special
Record Date, or be paid at any time in any other lawful manner not inconsistent with the
requirements of any securities exchange on which the Securities of this series may be listed, and
upon such notice as may be required by such exchange, all as more fully provided in the Indenture.

     Payment of the principal of (and premium, if any) and any such interest on this Security will
be made at the office or agency of the Company maintained for that purpose in New York, New York,
in such coin or currency of the United States of America as at the time of payment is legal tender
for payment of public and private debts; provided, however, that at the option of
the Company payment of interest may be made by check mailed to the address of the Person entitled
thereto as such address shall appear in the Security Register.

     Reference is hereby made to the further provisions of this Security set forth on the reverse
hereof, which further provisions shall for all purposes have the same effect as if set forth at
this place.

     Unless the certificate of authentication hereon has been manually executed by or on behalf of
the Trustee under the Indenture referred to on the reverse hereof, this Security shall not be
entitled to any benefit under the Indenture or be valid or obligatory for any purpose.

2

 

     IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed under its
corporate seal.

Dated: April 7, 2009

	 	 	 	 	 	 	 	 	 	 	 
	Trustee’s Certificate of Authentication:	 	 	 	COCA-COLA BOTTLING CO. CONSOLIDATED	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	This is one of the Securities of the series

designated herein referred to in the within-

mentioned Indenture.	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	The Bank of New York Mellon Trust	 	 	 	By:	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	Company, NA	 	 	 	 	 	James E. Harris	 	 
	 

	 	 	 	 	 	 	 	Senior Vice President and Chief Financial	 	 
	 

	 	 	 	 	 	 	 	Officer	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:
	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	Authorized Officer
	 	 	 	Attest:	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	Mark S. Powers	 	 
	 

	 	 	 	 	 	 	 	Assistant Secretary	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	[SEAL]	 	 

3

 

[REVERSE SIDE OF SECURITY]

COCA-COLA BOTTLING CO. CONSOLIDATED

7.00% Senior Note Due 2019

     This Security is one of a duly authorized issue of securities of the Company (herein called
the “Securities”), issued and to be issued in one or more series under an Indenture dated as of
July 20, 1994, as supplemented and restated by the Supplemental Indenture dated March 3, 1995 (as
supplemented and restated, the “Indenture”), between the Company and The Bank of New York Mellon
Trust Company, N.A., as successor trustee (pursuant to an Agreement of Resignation, Appointment and
Acceptance dated January 15, 2007), and any other successor trustee under the Indenture, to which
Indenture and all indentures supplemental thereto reference is hereby made for a statement of the
respective rights, limitations of rights, duties and immunities thereunder of the Company, the
Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are
to be, authenticated and delivered. This Security is one of the series designated on the face
hereof, limited in aggregate principal amount to $110,000,000.

     The Securities are redeemable, as a whole or in part, at the option of the Company, at any
time or from time to time, on at least 30 days, but not more than 60 days, prior notice mailed to
the registered address of each Holder of Securities of this series. The redemption prices will be
equal to the greater of (1) 100% of the principal amount of the Securities of this series being
redeemed or (2) the sum of the present values of the remaining scheduled payments of principal and
interest (exclusive of interest accrued to the Redemption Date) discounted to the Redemption Date
on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months), at a rate equal
to the sum of the Treasury Rate (as defined below) plus 50 basis points. In the case of each of
clause (1) and (2), accrued and unpaid on the principal amount will be paid to the Redemption Date.

     “Comparable Treasury Issue” means the United States Treasury security selected by a Reference
Treasury Dealer as having a maturity comparable to the remaining term of Securities of this series
that would be utilized, at the time of selection and in accordance with customary financial
practice, in pricing new issues of corporate debt securities of comparable maturity to the
remaining term of Securities of this series.

     “Comparable Treasury Price” means, with respect to any redemption date, (A) the average of the
Reference Treasury Dealer Quotations for such redemption date, after excluding the highest and
lowest such Reference Treasury Dealer Quotations, (B) if the Trustee obtains fewer than three such
Reference Treasury Dealer Quotations, the average of all such quotations or (C) if only one
Reference Treasury Dealer Quotation is received, such quotation.

     “Reference Treasury Dealer” means (1) Citigroup Global Markets Inc. (or its affiliates which
are Primary Treasury Dealers) and its successors; provided, however, that if the foregoing shall
cease to be a primary U.S. Government securities dealer in New York City (a “Primary Treasury
Dealer”), the Company will substitute therefore another Primary Treasury Dealer; and (2) any other
Primary Treasury Dealer(s) selected by the Company.

     “Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer
and any redemption date, the average, as determined by the Trustee, of the bid and asked prices for
the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount)
quoted in writing to the Trustee by such Reference Treasury Dealer at 3:30 p.m., New York City
time, on the third business day preceding such redemption date.

     “Treasury Rate” means, with respect to any redemption date, the rate per annum equal to the
semiannual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the

4

 

Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the
Comparable Treasury Price for such redemption date.

     On and after the redemption date, interest will cease to accrue on Securities of this series
called for redemption (unless the Company defaults in the payment of the redemption price and
accrued interest). On or before the redemption date, the Company will deposit with a paying agent
(or the Trustee) money sufficient to pay the redemption price and accrued interest on the
Securities of this series to be redeemed on such date. If less than all of the Securities of this
series are to be redeemed, the Securities of this series to be redeemed shall be selected by the
Trustee by such method as the Trustee shall deem fair and appropriate.

     Upon the occurrence of a Change of Control Triggering Event (as defined below), unless the
Company has exercised its right to redeem the Securities, each Holder of Securities will have the
right to require the Company to purchase all or a portion (equal to an integral multiple of $1,000)
of such Holder’s Securities pursuant to the offer described below (the “Change of Control Offer”);
provided that the principal amount of a Security outstanding after a repurchase in part shall be
$1,000 or an integral multiple thereof. In the Change of Control Offer, the Company will offer to
purchase the Securities for a purchase price equal to 101% of the principal amount thereof plus
accrued and unpaid interest, if any, to the date of purchase, subject to the rights of Holders of
Securities on the relevant record date to receive interest due on the relevant interest payment
date.

     Within 30 days following any Change of Control Triggering Event, or at the Company’s option,
prior to any Change of Control (as defined below) but after the public announcement of the pending
Change of Control, the Company shall send, by first class mail, a notice to each Holder of
Securities, with a copy to the Trustee, which notice will govern the terms of the Change of Control
Offer. Such notice will state, among other things, the purchase date, which must be no earlier
than 30 days nor later than 60 days from the date such notice is mailed, other than as may be
required by law (the “Change of Control Payment Date”). The notice, if mailed prior to the date of
consummation of the Change of Control, will state that the Change of Control Offer is conditioned
on the Change of Control being consummated on or prior to the Change of Control Payment Date.

     On the Change of Control Payment Date, the Company will, to the extent lawful:

	 	•	 	accept for payment all Securities or portions of Securities properly tendered
pursuant to the Change of Control Offer;
	 
	 	•	 	deposit with the paying agent an amount equal to the Change of Control payment
in respect of all Securities or portions of Securities properly tendered; and
	 
	 	•	 	deliver or cause to be delivered to the Trustee the Securities properly
accepted together with an officers’ certificate stating the aggregate principal amount
of Securities or portions of Securities being purchased by the Company and the amount
to be paid by the paying agent.

     The Company will not be required to make a Change of Control Offer if a third party makes such
an offer in the manner, at the times and otherwise in compliance with the requirements for such an
offer made by the Company and such third party purchases all Securities properly tendered and not
withdrawn under its offer. In addition, the Company will not repurchase any Securities if there
has occurred and is continuing on the Change of Control Payment Date an event of default under the
Indenture, other than a default in the payment of the Change of Control payment upon a Change of
Control Triggering Event.

     The Company will be required to comply with the requirements of Rule 14e-1 under the Exchange
Act, and any other securities laws and regulations thereunder to the extent those laws and
regulations are applicable in connection with the repurchase of the Securities as a result of a
Change of Control Triggering

5

 

Event. To the extent that the provisions of any securities laws or
regulations conflict with the Change of Control Offer provisions of the Securities, the Company
will be required to comply with those securities laws and regulations and will not be deemed to
have breached its obligations under the Change of Control Offer provisions of the Securities by
virtue of any such conflict and compliance.

     “Acquiring Person” means any “person” (as that term is used in Section 13(d)(3) of the
Exchange Act) other than (a) the Company or one or more of its Subsidiaries, (b) The Coca-Cola
Company or one or more of its Subsidiaries or (c) J. Frank Harrison, III or one or more Harrison
Family Members.

     “Change of Control” means the occurrence of any one of the following:

     (1) the direct or indirect sale, lease, transfer, conveyance or other disposition
(other than by way of merger or consolidation), in one or a series of related transactions,
of all or substantially all of the Company’s and its Subsidiaries’ assets taken as a whole
to any Acquiring Person;

     (2) the consummation of any transaction (including without limitation, any merger or
consolidation) the result of which is that any Acquiring Person becomes the “beneficial
owner” (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly,
of more than 50% of the outstanding Voting Equity of the Company, measured by voting power
rather than number of shares;

     (3) the Company consolidates with, or merges with or into, any Acquiring Person, or any
Acquiring Person consolidates with, or merges with or into, the Company, in any such event
pursuant to a transaction in which any of the Company’s outstanding Voting Equity or the
Voting Equity of such other Acquiring Person is converted into or exchanged for cash,
securities or other property, other than any such transaction where the shares of the Voting
Equity of the Company outstanding immediately prior to such transaction constitute, or are
converted into or exchanged for, a majority of the Voting Equity of the surviving Person
immediately after giving effect to such transaction;

     (4) the first day on which the majority of the members of the Board of Directors of the
Company cease to be Continuing Directors;

     (5) the adoption of a plan relating to the liquidation or dissolution of the Company;
or

     (6) the consummation of a so-called “going private/Rule 13e-3 Transaction” that results
in any of the effects described in paragraph (a)(3)(ii) of Rule 13e-3 under the Exchange Act
(or any successor provision), following which J. Frank Harrison, III or any Harrison Family
Members beneficially own, directly or indirectly, more than 50% of the Voting Equity of the
Company, measured by voting power rather than number of shares.

     Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control
under clause (2) above if (i) the Company becomes a direct or indirect wholly-owned Subsidiary of a
holding company and (ii)(A) the direct or indirect holders of the Voting Equity of such holding
company immediately following that transaction are substantially the same as the holders of the
Voting Equity of the Company immediately prior to that transaction or (B) immediately following
that transaction no Person (other than a holding company satisfying the requirements of this
sentence) is the beneficial owner, directly or indirectly, of more than 50% of the Voting Equity of
such holding company.

     “Change of Control Triggering Event” means the Securities cease to be rated Investment Grade
by both of the Rating Agencies on any date during the period (the “Trigger Period”) commencing 60
days prior to the first public announcement by the Company of any Change of Control (or pending
Change of Control)

6

 

and ending 60 days following consummation of such Change of Control (which
Trigger Period will be extended following consummation of a Change of Control for so long as any of
the Rating Agencies has publicly announced that it is considering a possible ratings change).
Unless both of the Rating Agencies are providing a rating for the Securities at the commencement of
any Trigger Period, the Securities will be deemed to have ceased to be rated Investment Grade by
both of the Rating Agencies during that Trigger Period. Notwithstanding the foregoing, no Change
of Control Triggering Event will be deemed to have occurred in connection with any particular
Change of Control unless and until such Change of Control has actually been consummated.

     “Continuing Director” means, as of any date of determination, any member of the Board of
Directors of the Company who: (1) was a member of such board of directors on the date the
Securities were issued; or (2) was nominated for election or elected to such board of directors
with the approval of a majority of the Continuing Directors who were members of such board of
directors at the time of such nomination or election.

     “Harrison Family Individuals” means (a) J. Frank Harrison, III, (b) his spouse and (c) the
lineal descendants of J. Frank Harrison, Jr.

     “Harrison Family Member” means (a) Harrison Family Individuals, (b) trusts, corporations,
partnerships, limited partnerships, limited liability companies or other estate planning vehicles
for the benefit of Harrison Family Individuals or (c) any other Person; provided that, with respect
to clauses (b) and (c), in the case of a trust, a majority of the trustees are Harrison Family
Individuals, and in the case of any Person, one or more Harrison Family Individuals is the
“beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or
indirectly, of more than 50% of the Voting Equity, measured by voting power rather than number of
shares of such Person.

     “Investment Grade” means a rating of Baa3 or better by Moody’s (or its equivalent under any
successor rating category of Moody’s) and a rating of BBB- or better by S&P (or its equivalent
under any successor rating category of S&P).

     “Moody’s” means Moody’s Investors Service, Inc., a subsidiary of Moody’s Corporation, and its
successors.

     “Rating Agency” means each of Moody’s and S&P; provided, that if either Moody’s or S&P ceases
to rate the Securities or fails to make a rating of the Securities publicly available for reasons
outside of the Company’s control, a “nationally recognized statistical rating organization” within
the meaning of Rule 15c3-1(c)(2)(vi)(F) under the Exchange Act selected by the Company (as
certified by a resolution of the Board of Directors of the Company) as a replacement agency for
Moody’s or S&P, or both of them, as the case may be.

     “S&P” means Standard & Poor’s Ratings Services, a division of The McGraw-Hill Companies, Inc.,
and its successors.

     “Subsidiary” means, with respect to any Person, any corporation, partnership, limited
liability company or other entity of which securities or other ownership interests having the power
to elect a majority of the board of directors or other Persons performing similar functions of such
corporation, partnership, limited liability company or other entity are directly or indirectly
owned or controlled by such Person or one or more Subsidiaries of such Person; provided, however,
that Piedmont Coca-Cola Bottling Partnership shall be deemed to be a Subsidiary of the Company so
long as the Company owns greater than a 50% economic interest therein.

7

 

     “Voting Equity” of any specified Person as of any date means the securities or other ownership
interests of such Person that are at the time entitled to vote generally in the election of the
board of directors of such Person or other Persons performing similar functions.

     The Indenture contains provisions for defeasance at any time of (a) the entire indebtedness
represented by this Security and (b) certain restrictive covenants, in each case upon compliance by
the Company with certain conditions set forth therein, which provisions apply to this Security.

     The Company may, from time to time, subject to compliance with the applicable provisions of
the Indenture, without giving notice to or seeking the consent of the Holders, create and issue
additional securities having a ranking, interest rate, maturity and other terms and conditions
identical to those of this Security except for the issue date and any other terms specified by the
Company in order to facilitate the original issuance of such other securities. Any such securities
will, to the extent the Company so provides, constitute a single series of securities under the
Indenture.

     If an Event of Default with respect to this Security shall occur and be continuing, the
principal of this Security may be declared due and payable in the manner and with the effect
provided in the Indenture.

     The Indenture permits, with certain exceptions as therein provided, the amendment thereof and
the modification of the rights and obligations of the Company and the rights of the Holders of the
Securities of each series to be affected under the Indenture at any time by the Company and the
Trustee with the consent of the Holders of not less than a majority in principal amount of the
Securities at the time Outstanding of each series affected. The Indenture also contains provisions
permitting the Holders of specified percentages in principal amount of the Securities of each
series at the time Outstanding, on behalf of the Holders of all Securities of such series, to waive
compliance by the Company with certain provisions of the Indenture and certain past defaults under
the Indenture and their consequences. Any such consent or waiver by the Holder of this Security
shall be conclusive and binding upon such Holder and upon all future Holders of this Security and
of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu
hereof whether or not notation of such consent or waiver is made upon this Security.

     No reference herein to the Indenture and no provision of this Security or of the Indenture
shall alter or impair the right of the Holder of this Security, which is absolute and
unconditional, to receive payment of the principal of (and premium, if any) and, subject to Section
307 of the Indenture, interest on this Security at the times, place and rate, and in the coin or
currency, herein prescribed.

     As long as this Security is represented in global form registered in the name of the
Depositary or its nominee (a “Global Security”), except as provided in the Indenture, and subject
to certain limitations therein set forth, no Global Security shall be exchangeable or transferable,
except as a whole, by the Depositary to a nominee of the Depositary or by a nominee of the
Depositary to another nominee of the Depositary or by the Depositary or any such nominee to a
successor Depositary or a nominee of such successor depositary.

     The Securities of this series are issuable only in registered form without coupons in
denominations of $1,000 and any integral multiples of $1,000 in excess thereof.

     No service charge shall be made for any such registration of transfer or exchange, but the
Company may require payment of a sum sufficient to cover any tax or other governmental charge
payable in connection therewith.

     Prior to due presentment of this Security for registration of transfer, the Company, the
Trustee and any agent of the Company or the Trustee may treat the Person in whose name this
Security is registered as the owner hereof for all purposes, whether or not this Security be
overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the
contrary.

8

 

     Unless otherwise defined in this Security, all terms used in this Security which are defined
in the Indenture shall have the meanings assigned to them in the Indenture.

9

 

ASSIGNMENT

     FOR VALUE RECEIVED the undersigned hereby sells, assigns and transfers unto

	 	 	 
	PLEASE INSERT SOCIAL SECURITY OR OTHER

	 	 
	IDENTIFYING NUMBER OF ASSIGNEE
	 	 

      

(Name and address of assignee, including zip code, must be printed or typewritten)

      

      

the within Security, and all rights thereunder, hereby irrevocably constituting and appointing

      

Attorney to transfer said Security on the books of the within Company, with full power of
substitution in the premises.

	 	 	 	 	 	 	 	 	 
	Dated:

	 	 	 	 	 	Your Signature:	 	 
	 

	 	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	NOTICE: The signature to this assignment
must correspond with the name as it
appears upon the face of the within or
attached Security in every particular,
without alteration or enlargement or any
change whatever.

	 	 	 
	Signature Guarantee:EX-10.1

Exhibit 10.1

INDEMNIFICATION AGREEMENT

     This Indemnification Agreement (the “Agreement”) made and entered into as of the
Effective Date (defined below) by and between Wright Medical Group, Inc., a Delaware
corporation (the “Company”), and [Name] (the “Indemnitee”).

     WHEREAS, it is essential to the Company and its Affiliates (defined below) to retain and
attract the most capable persons available as directors and officers;

     WHEREAS, directors and officers of public companies are subject to an increased risk of
litigation and claims being asserted against them;

     WHEREAS, the Company’s Fourth Amended and Restated Certificate of Incorporation, as amended by
Certificate of Amendment of Fourth Amended and Restated Certificate of Incorporation (the
“Certificate of Incorporation”) and Second Amended and Restated By-laws (the
“By-laws”) of the Company require the Company to indemnify its directors and officers and
those serving its Affiliates at its request to the fullest extent permitted by Delaware law, and
the Indemnitee has been serving and continues to serve as a director or officer of the Company or
an Affiliate of the Company in part in reliance on such Certificate of Incorporation and By-laws;

     WHEREAS, Indemnitee is or has agreed to become or will continue to serve as a director or
officer of the Company or an Affiliate of the Company;

     WHEREAS, the Company desires (i) to provide Indemnitee with specific contractual assurance
that the protection promised by such Certificate of Incorporation and By-laws will be available to
Indemnitee (regardless of, among other things, any amendment to or revocation of such Certificate
of Incorporation or By-laws, change in the composition of the Company’s Board of Directors
(“Board of Directors”), or any change in the ownership of the Company), (ii) to provide for
the indemnification of and the advancing of expenses to Indemnitee to the fullest extent (whether
partial or complete) permitted by law and as set forth in this Agreement, and (iii) to the extent
insurance is available, to provide for continued coverage of Indemnitee under the Company’s
directors and officers liability insurance policies; and

     WHEREAS, Indemnitee is relying upon the rights afforded under this Agreement in accepting or
continuing Indemnitee’s position as a director or officer of the Company or an Affiliate of the
Company.

     NOW, THEREFORE, in consideration of the Indemnitee’s agreement to serve or continue to serve
as a director and/or officer of the Company or an Affiliate of the Company and of other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company
has agreed to the covenants set forth herein for the purpose of further securing to the Indemnitee
the indemnification provided by the Certificate of Incorporation and the By-laws:

	1.	 	Definitions.

(a) “Affiliate” has the meaning set forth in Rule 12b-2 promulgated under
the Securities Exchange Act of 1934, as amended, and the applicable rules and
regulations thereunder.

(b) “Agreement” shall have the meaning specified in the introductory
paragraph hereof.

(c) “By-laws” shall have the meaning specified in the Recitals hereto.

(d) “Certificate of Incorporation” shall have the meaning specified in the
Recitals hereto.

(e) “Change in Control” shall be deemed to have occurred if (i) any “person”
(as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of
1934, as amended), other than a trustee or other fiduciary holding securities under
an employee benefit plan of the Company or a

 

 

corporation owned directly or
indirectly by the stockholders of the Company in substantially the same proportions
as their ownership of stock of the Company, is or becomes the “beneficial owner” (as
defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the
Company representing 20% or more of the total voting power represented by the
Company’s then outstanding Voting Securities, or (ii) during any period of two
consecutive years, individuals who at the beginning of such period constitute the
Board of Directors and any new director whose election by the Board of Directors or
nomination for election by the Company’s stockholders was approved by a vote of at
least two-thirds of the directors then still in office who either were directors at
the beginning of the period or whose election or nomination for election was
previously so approved, cease for any reason to constitute a majority thereof, or
(iii) the stockholders of the Company approve a merger or consolidation of the
Company with any other corporation, other than a merger or consolidation which would
result in the Voting Securities of the Company outstanding immediately prior thereto
continuing to represent (either by remaining outstanding or by being converted into
Voting Securities of the surviving entity) at least 80% of the total voting power
represented by the Voting Securities of the Company or such surviving entity
outstanding immediately after such merger or consolidation, or the stockholders of
the Company approve a plan of complete liquidation of the Company or an agreement
for the sale or disposition by the Company of (in one transaction or a series of
transactions) all or substantially all the Company’s assets.

(f) “Claim” means any threatened, pending, or completed action, suit, or
proceeding, or any inquiry or investigation, whether instituted by the Company or
any other party, that Indemnitee in good faith believes might lead to the
institution of any such action, suit, or proceeding, whether civil, criminal,
administrative, investigative, or other and whether formal or informal.

(g) “Company” shall have the meaning specified in the introductory paragraph
hereof.

(h) “Expense Advance” shall have the meaning specified in Section
2.2.

(i) “Expenses” include attorneys’ fees and all other costs, expenses and
obligations (including, without limitation, experts’ fees, court costs, retainers,
transcript fees, duplicating, printing and binding costs, as well as
telecommunications, postage and courier charges) paid or incurred in connection with
investigating, defending, being a witness in or participating in, or preparing to
investigate, defend, be a witness in or participate in, any Claim relating to any
Indemnifiable Event.

(j) “Indemnifiable Amounts” include any and all Expenses, damages,
judgments, fines, penalties, excise taxes and amounts paid in settlement (including
all interest, assessments and other charges paid or payable in connection with or in
respect of such Expenses, judgments, fines, penalties, excise taxes or amounts paid
in settlement) arising out of or resulting from any Claim relating to an
Indemnifiable Event.

(k) “Indemnifiable Event” means any event or occurrence related to the fact
that Indemnitee is or was a director, officer, employee, or agent of the Company or
an Affiliate of the Company, or is or was serving at the request of the Company as a
director, officer, partner, trustee, employee, or agent of another foreign or
domestic corporation, partnership, joint venture, trust or other enterprise, whether
for profit or not, or by reason of anything done or not done by Indemnitee in any
such capacity.

(l) “Indemnitee” shall have the meaning specified in the introductory
paragraph hereof.

(m) “Independent Legal Counsel” means an attorney or firm of attorneys,
selected in accordance with the provisions of Section 3, who shall not have
otherwise performed services for

2

 

the Company or Indemnitee within the last five (5)
years (other than with respect to matters concerning the rights of Indemnitee under
this Agreement, or of other indemnities under similar indemnity agreements).

(n) “Reviewing Party” means any appropriate person or body consisting of a
member or members of the Board of Directors or any other person or body appointed by
the Board who is not a party to the particular Claim for which Indemnitee is seeking
indemnification, or Independent Legal Counsel.

(o) “Voting Securities” are any securities of the Company that vote
generally in the election of directors.

	2.	 	Basic Indemnification Arrangement; Advancement of Expenses.

	 	2.1.	 	In the event Indemnitee was, is or becomes a party to or witness or other
participant in, or is threatened to be made a party to or witness or other participant
in, a Claim by reason of (or arising in part out of) an Indemnifiable Event, the
Company shall indemnify Indemnitee to the fullest extent permitted by law as soon as
practicable, but in any event no later than thirty days after written demand is
presented to the Company, against any and all Indemnifiable Amounts. For the avoidance
of doubt, the foregoing indemnification obligation includes, without limitation, claims
for monetary damages against Indemnitee in respect of an alleged breach of fiduciary
duties, to the fullest extent permitted under Section 102(b)(7) of the Delaware General
Corporation Laws.
	 
	 	2.2.	 	If requested by Indemnitee, the Company shall advance (within five (5) business
days of such request) any and all Expenses incurred by Indemnitee (an “Expense
Advance”). The Company shall, in accordance with such request (but without
duplication), either (i) pay such Expenses on behalf of Indemnitee, or (ii) reimburse
Indemnitee for such Expenses. Subject to the limitations contained in Sections 2.3
and 2.4, Indemnitee’s right to an Expense Advance is absolute and shall not be
subject to any prior determination by the Reviewing Party or any other person, that the
Indemnitee has satisfied any applicable standard of conduct for indemnification. In
making any request for an Expense Advance, Indemnitee shall submit to the Company a
schedule setting forth in reasonable detail the dollar amount expended or incurred and
expected to be expended or incurred. Each such listing shall be supported by the bill,
agreement, or other documentation relating thereto, each of which shall be appended to
the schedule as an exhibit.
	 
	 	2.3.	 	Notwithstanding anything in this Agreement to the contrary, Indemnitee shall
not be entitled to indemnification or an Expense Advance pursuant to this Agreement in
connection with any Claim initiated by Indemnitee unless (i) the Company has joined in
or the Board of Directors has authorized or consented to the initiation of such Claim
or (ii) the Claim is one to enforce Indemnitee’s rights under this Agreement.
	 
	 	2.4.	 	Notwithstanding anything in this Agreement to the contrary, (i) the
indemnification obligations of the Company under Section 2.1 shall be subject
to the condition that the Reviewing Party shall not have determined (in a written
opinion, in any case in which the Independent Legal Counsel is involved) that
Indemnitee would not be permitted to be indemnified under applicable law, and (ii) the
obligation of the Company to make an Expense Advance pursuant to Section 2.2
shall be subject to the condition that, if, when and to the extent that the Reviewing
Party determines that Indemnitee would not be permitted to be so indemnified under
applicable law, the Company shall be entitled to be reimbursed by Indemnitee (who
hereby agrees to reimburse the Company) for all such amounts theretofore paid (it being
understood and agreed that the foregoing agreement by Indemnitee shall be deemed to
satisfy any requirement that Indemnitee provide the Company with an undertaking to
repay any Expense Advance if it is ultimately determined that the Indemnitee is
not entitled to indemnification under applicable law); provided,
however, that if Indemnitee has commenced or thereafter commences legal
proceedings in a court of competent jurisdiction to

3

 

	 	 	 	secure a determination that
Indemnitee should be indemnified under applicable law, any determination made by the
Reviewing Party that Indemnitee would not be permitted to be indemnified under
applicable law shall not be binding and Indemnitee shall not be required to
reimburse the Company for any Expense Advance until a final judicial determination
is made with respect thereto (as to which all rights of appeal therefrom have been
exhausted or lapsed). Indemnitee’s undertaking to repay such Expense Advances shall
be unsecured and interest-free. If there has not been a Change in Control, the
Reviewing Party shall be selected by the Board of Directors, and if there has been
such a Change in Control, the Reviewing Party shall be the Independent Legal
Counsel. If there has been no determination by the Reviewing Party within thirty
(30) days after written demand is presented to the Company or if the Reviewing Party
determines that Indemnitee would not be permitted to be indemnified in whole or in
part under applicable law, Indemnitee shall have the right to commence litigation in
any court in the State of Delaware having subject matter jurisdiction thereof and in
which venue is proper seeking an initial determination by the court or challenging
any such determination by the Reviewing Party or any aspect thereof, including the
legal or factual bases therefor, and the Company hereby consents to service of
process and to appear in any such proceeding. Any determination by the Reviewing
Party otherwise shall be conclusive and binding on the Company and Indemnitee.

	3.	 	Change in Control. The Company agrees that if there is a Change in Control of the
Company (other than a Change in Control which has been approved by a majority of the Board of
Directors who were directors immediately prior to such Change in Control) then with respect to
all matters thereafter arising concerning the rights of Indemnitee to indemnity payments and
any Expense Advance under this Agreement or any other agreement or the Certificate of
Incorporation or By-laws, now or later in effect, relating to Claims for Indemnifiable Events,
the Company shall seek legal advice only from Independent Legal Counsel selected by Indemnitee
and approved by the Company (which approval shall not be unreasonably withheld). The Company
agrees to pay the reasonable fees of the Independent Legal Counsel referred to above and to
indemnify fully such counsel against any and all expenses (including attorneys’ fees), claims,
liabilities and damages arising out of or relating to this Agreement or its engagement
pursuant hereto.
	 
	4.	 	Indemnification for Additional Expenses. The Company shall indemnify Indemnitee
against any and all expenses (including attorneys’ fees) and, if requested by Indemnitee,
shall (within five (5) business days of such request) advance such expenses to Indemnitee,
which are incurred by Indemnitee in connection with any action brought by Indemnitee for (i)
indemnification or advance payment of Expenses by the Company under this Agreement or any
other agreement or the Certificate of Incorporation or By-laws, now or later in effect
relating to Claims for Indemnifiable Events and/or (ii) recovery under any directors and
officers liability insurance policies maintained by the Company, regardless of whether
Indemnitee ultimately is determined to be entitled to such indemnification, advance expense
payment, or insurance recovery, as the case may be.
	 
	5.	 	Partial Indemnity. If Indemnitee is entitled under any provision of this Agreement
to indemnification by the Company for some or a portion of the Expenses, judgments, fines,
penalties, and amounts paid in settlement of a Claim but not, however, for all of the total
amount of the Claim, the Company shall nevertheless indemnify Indemnitee for the portion of
the Claim to which Indemnitee is entitled. Notwithstanding any other provision of this
Agreement, to the extent that Indemnitee has been successful on the merits or otherwise in
defense of any or all Claims relating in whole or in part to an Indemnifiable Event or in
defense of any issue or matter related to an Indemnifiable Event, including dismissal without
prejudice, Indemnitee shall be indemnified against all Expenses incurred in connection
therewith.
	 
	6.	 	Burden of Proof. In connection with any determination by the Reviewing Party or
otherwise as to whether Indemnitee is entitled to be indemnified hereunder the Reviewing Party
or court shall presume that the Indemnitee has satisfied the applicable standard of conduct
and is entitled to indemnification, and the burden of proof shall be on the Company to
establish, by clear and convincing evidence, that Indemnitee is not so entitled.

4

 

	7.	 	Reliance. For purposes of this Agreement, Indemnitee shall be deemed to have acted
in good faith and in a manner he or she reasonably believed to be in or not opposed to the
best interests of the Company if Indemnitee’s actions or omissions to act are taken in good
faith reliance upon the records of the Company, including its financial statements, or upon
information, opinions, reports or statements furnished to Indemnitee by the officers or
employees of the Company in the course of their duties, or by committees of the Board of
Directors, or by any other person (including legal counsel, accountants, consultants and
financial advisors) as to matters Indemnitee reasonably believes are within such other
person’s professional or expert competence and who has been selected with reasonable care by
or on behalf of the Company. In addition, the knowledge and/or actions, or failures to act,
of any other director, officer, agent or employee of the Company shall not be imputed to
Indemnitee for purposes of determining the right to indemnity hereunder.
	 
	8.	 	No Presumptions. For purposes of this Agreement, the termination of any claim,
action, suit, or proceeding by judgment, order, settlement (whether with or without court
approval), or conviction, or upon a plea of nolo contendere or its equivalent shall not create
a presumption that Indemnitee did not meet any particular standard of conduct or have any
particular belief or that a court has determined that indemnification is not permitted by
applicable law. In addition, neither the failure of the Company (including, without
limitation, the Board of Directors, any committee of the Board of Directors, legal counsel, or
the stockholders) to have made a determination as to whether Indemnitee has met any particular
standard of conduct or had any particular belief, nor an actual determination by the Company
(including, without limitation, the Board of Directors, any committee of the Board of
Directors, legal counsel, or the stockholders) that Indemnitee has not met such standard of
conduct or did not have such belief, prior to the commencement of legal proceedings by
Indemnitee to secure a judicial determination that Indemnitee should be indemnified under
applicable law shall be a defense to Indemnitee’s claim or create a presumption that
Indemnitee has not met any particular standard of conduct or did not have any particular
belief.
	 
	9.	 	Nonexclusivity. The rights of the Indemnitee under this Agreement shall be in
addition to any other rights that Indemnitee may have under the Company’s Certificate of
Incorporation or By-laws or the General Corporation Law of the State of Delaware. To the
extent that a change in the General Corporation Law of the State of Delaware (whether by
statute or judicial decision) permits greater indemnification by agreement than would be
afforded currently under the Certificate of Incorporation, By-laws or this Agreement, it is
the intent of the Company and Indemnitee that Indemnitee shall enjoy by this Agreement the
greater benefits so afforded by such change.
	 
	10.	 	Amendments; Waiver. No supplement, modification, or amendment of this Agreement
shall be binding unless executed in writing by the Company and Indemnitee. No waiver of any
of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other
provisions of this Agreement, nor shall such waiver constitute a continuing waiver.
	 
	11.	 	Insurance and Subrogation.

	 	11.1.	 	To the extent the Company or an Affiliate of the Company maintains an
insurance policy or policies providing directors and officers liability insurance,
Indemnitee shall be covered by such policy or policies in accordance with its or their
terms and to the maximum extent of the coverage available for any Company or Affiliate
director or officer.
	 
	 	11.2.	 	The Company represents that it presently has in force and effect directors and
officers liability insurance on behalf of Indemnitee against certain customary
liabilities which may be asserted against or incurred by Indemnitee. The Company
hereby agrees that, so long as Indemnitee shall continue to serve as a director or
officer, and thereafter so long as Indemnitee shall be subject to any possible claim or
threatened, pending or completed proceeding, whether civil, criminal, administrative or
investigative, by reason of the fact that Indemnitee served as an officer or director,
the Company shall purchase and maintain in effect for the benefit of Indemnitee such
insurance providing (a) coverage at least comparable to that presently provided or (b)
if such

5

 

	 	 	 	coverage is hereafter changed to provide any enhanced rights or benefits, the same
coverage provided to the most favorably insured of the Company’s directors or
officers; provided, however, if, the then Board of Directors
determines in good faith that, either (x) the premium cost for such insurance is
substantially disproportionate to the amount of coverage, or (y) the coverage
provided by such insurance is so limited by exclusions that there is insufficient
benefit from such insurance, then and in that event, the Company shall not be
required to maintain such insurance; provided further, however,
that if, after a Change in Control, the Board of Directors determines that the
Company shall not be required to maintain such insurance, the Company shall be
required to purchase a “tail” policy which (i) has an effective term of six (6)
years from a Change in Control, (ii) covers Indemnitee for actions and omissions
occurring on or prior to the date of the Change in Control, (iii) contains terms and
conditions that are, in the aggregate, no less favorable to Indemnitee than those of
the Indemnitee immediately prior to the Change in Control. The Company shall
promptly notify Indemnitee of any good faith determination to reduce or not provide
such coverage.
	 
	 	11.3.	 	In the event of payment under this Agreement, the Company shall be subrogated
to the extent of such payment to all of the rights of recovery of Indemnitee, who shall
execute all papers required and shall do everything that may be reasonably necessary to
secure such rights, including the execution of such documents reasonably necessary to
enable the Company effectively to bring suit to enforce such rights.

	12.	 	No Duplication of Payments. The Company shall not be liable under this Agreement to
make any payment in connection with any Claim made against Indemnitee to the extent Indemnitee
has otherwise actually received payment (under any insurance policy, provision of the
Certificate of Incorporation, By-law or otherwise) of the amounts otherwise indemnifiable
under this Agreement.
	 
	13.	 	Defense of Claims. The Company shall be entitled to participate in the defense of
any Claim relating to an Indemnifiable Event or to assume the defense of such Claim, with
counsel reasonably satisfactory to the Indemnitee; provided, however, that if
Indemnitee believes, after consultation with counsel selected by Indemnitee, that (i) the use
of counsel chosen by the Company to represent Indemnitee would present such counsel with an
actual or potential conflict of interest, (ii) the named parties in any such Claim (including
any impleaded parties) include both the Company and Indemnitee and Indemnitee concludes that
there may be one or more legal defenses available to him or her that are different from or in
addition to those available to the Company, or (iii) any such representation by such counsel
would be precluded under the applicable standards of professional conduct then prevailing,
then Indemnitee shall be entitled to retain separate counsel (but not more than one law firm
plus, if applicable, local counsel in respect of any particular Claim) at the Company’s
expense. The Company shall not be liable to Indemnitee under this Agreement for any amounts
paid in settlement of any Claim relating to an Indemnifiable Event effected without the
Company’s prior written consent. The Company shall not, without the prior written consent of
the Indemnitee, effect any settlement of any Claim relating to an Indemnifiable Event which
the Indemnitee is or could have been a party unless such settlement solely involves the
payment of money and includes a complete and unconditional release of Indemnitee from all
liability on all claims that are the subject matter of such Claim. Neither the Company nor
Indemnitee shall unreasonably withhold its or his or her consent to any proposed settlement;
provided that Indemnitee may withhold consent to any settlement that does not provide a
complete and unconditional release of Indemnitee.
	 
	14.	 	Binding Effect. This Agreement shall be binding upon and inure to the benefit of and
be enforceable by the parties hereto and their respective successors, assigns, including any
direct or indirect successor by purchase, merger, consolidation, or otherwise to all or
substantially all of the business and/or assets of the Company, spouses, heirs, executors, and
personal and legal representatives. This Agreement shall continue in effect regardless of
whether Indemnitee continues to serve as a director or officer of the Company or of any other
enterprise at the Company’s request. The Company shall require and cause any successor to all
or substantially all of the business and/or assets of the Company, by written agreement in
form and substance satisfactory to Indemnitee and his or her counsel, expressly to assume and
agree to perform this

6

 

	 	 	Agreement in the same manner and to the same extent that the Company would be required to
perform if no such succession had taken place.
	 
	15.	 	Severability. The provisions of this Agreement shall be severable in the event that
any of the provisions hereof (including any provision within a single section, paragraph or
sentence) are held by a court of competent jurisdiction to be invalid, void, or otherwise
unenforceable in any respect, and the validity and enforceability of any such provision in
every other respect and of the remaining provisions of this Agreement shall not be in any way
impaired and shall remain enforceable to the fullest extent permitted by law.
	 
	16.	 	Governing Law. This Agreement shall be governed by and construed and enforced in
accordance with the laws of the State of Delaware applicable to contracts made and to be
performed in such state without giving effect to the principles of conflicts of laws.
	 
	17.	 	Specific Performance. The parties recognize that if any provision of this Agreement
is violated by the Company, Indemnitee may be without an adequate remedy at law. Accordingly,
in the event of any such violation, Indemnitee shall be entitled, if Indemnitee so elects, to
institute proceedings, either in law or at equity, to obtain damages, to enforce specific
performance, to enjoin such violation, or to obtain any relief or any combination of the
foregoing as Indemnitee may elect to pursue.
	 
	18.	 	Counterparts. This Agreement may be executed in counterparts, each of which shall
for all purposes be deemed to be an original but all of which together shall constitute one
and the same agreement. Only one such counterpart signed by the party against whom
enforceability is sought needs to be produced to evidence the existence of this Agreement.
	 
	19.	 	Entire Agreement. This Agreement constitutes the entire agreement between the
parties with respect to the subject matter hereof and supersedes all prior understandings and
agreements between the parties, whether written or oral, with respect to the subject matter
hereof.
	 
	 	 	IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective Date.

AGREED AND ACCEPTED

	 	 	 	 	 	 	 
	Accepted by Wright Medical Group, Inc. and effective as of	 	 	 	 
	                                   
                         (the
“Effective Date”)	 	 	 	 
	 
	 	 	 	 	 	 
	WRIGHT MEDICAL GROUP, INC.

	 	 	 	[NAME]	 	 
	 
	 	 	 	 	 	 
	By:
 
	 	 	 	  
	 	 
	 	 	 	 	 	 	 
	Title:
 

	 	 	 	 	 	 
	 

	 	 
	 	 

	 	 

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}]]